Syntec Optics (OPTX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
13 Feb, 2026Executive summary
Achieved record-high net sales in 2024, with continued growth in the first half of 2025, driven by strong demand in defense, biomedical, and communications markets.
Entered new energy end-markets and launched new products for AI-driven data centers and space-based applications.
Strengthened management team and invested $3.3 million in advanced equipment to support future growth.
Financial highlights
2024 net sales reached $28.4 million, up $1.9 million year-over-year; first half 2025 net sales were $13.6 million, up $0.3 million from prior year.
Adjusted EBITDA for 2024 was $2.2 million, down from $5.3 million in 2023 due to transition costs; first half 2025 adjusted EBITDA rose to $2.1 million, up $1.2 million year-over-year.
Gross margin improved from 22% in the first half of 2024 to 29% in the first half of 2025, with gross profit up $1.0 million.
Net income for the first half of 2025 was breakeven ($0.0 million), a $0.9 million improvement over the prior year.
Cash, including available lines of credit, was $4.3 million at June 30, 2025.
Outlook and guidance
Strategy focuses on operational excellence, scaling production, and expanding into new light-enabled markets.
Management expects continued gross profit improvement as yields and efficiencies increase.
Execution plan targets growth in LEO satellite optics, defense, AI data center optics, and biomedical diagnostics.
Latest events from Syntec Optics
- Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Q1 2025 net income turned positive on 13% sales growth and improved margins.OPTX
Q1 202513 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q2 sales up 12% sequentially, product growth strong, and Q3 outlook robust.OPTX
Q2 20242 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Virtual meeting to vote on directors, auditor, RSUs, and governance amendments; board recommends approval.OPTX
Proxy Filing8 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and RSU grants at the virtual annual meeting.OPTX
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, RSU grants, and governance amendments.OPTX
Proxy Filing29 Nov 2025